hotspot -WSS

hotspot

author：entertainment 2025-09-30 14:08:52 - browse：628

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： In utero gene editing: an explainer

entertainment

explore

WSS

EpiPen alternative approval delay highlights citizen petition issue

Alabama frozen embryo ruling has major implications for IVF clinics

PBM reform efforts get punted in Congress

Biotech stock slump in 2023: awaiting the turnaround

A solution to the after

New documents shed light on MD Anderson Cancer Institute feud

explore

hotspot

hotspot

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Thermo Fisher plant for manufacturing gene therapies to expand

Drug repurposing or repositioning? The language matters

Medicare inequities exacerbate Puerto Rico’s health disparities

ChatGPT in medicine: STAT answers readers' burning questions

The Harvard botanist who searched for psychedelics in the Amazon

Psychedelics group wrestles with new pharma identity

In utero gene editing: an explainer

hotspot

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Antivenom research: Lessons from HIV applied in search for universal antidote

Senators: Long

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

PBM reform efforts get punted in Congress

CDC advisers recommend seasonal use of Pfizer RSV shot

entertainment

entertainment

explore

focus